News from Decision Resources Group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 19, 2016, 08:09 ET Decision Resources Group Launches Intuitive New Platform to Access Real-Time Market Data

Decision Resources Group (DRG), a premier provider of high-value data, analytics and insights products and services to the healthcare industry,...


Jul 05, 2016, 11:00 ET The EU5 Market for Respiratory Drugs is Becoming Increasingly Crowded and Price-Sensitive

 Decision Resources Group finds that access and reimbursement for both chronic obstructive pulmonary disease (COPD) and asthma are becoming...


Jun 30, 2016, 10:00 ET Few Surveyed U.S. and European Neurologists Report High Satisfaction with the Efficacy of Antiepileptic Drugs Approved or Commonly Prescribed to Treat Seizures Associated with Lennox-Gastaut Syndrome

 Decision Resources Group finds that a majority of surveyed neurologists in the United States and Europe report only moderate satisfaction with...


Jun 29, 2016, 09:00 ET Overall Uptake and High Prescribing Rate in Retreatment for Gilead's Harvoni Solidify Its Stronghold on the Hepatitis C Market

 Decision Resources Group finds that despite increasing pressure from competitors, specifically AbbVie's Viekira Pak and Merck's Zepatier,...


Jun 13, 2016, 10:00 ET U.S. and European Endocrinologists See a Continued Need for New Nonstatin Drugs with Cardiovascular Outcomes Benefits for Dyslipidemias

 Decision Resources Group finds that despite the many therapies available, there is an ongoing need for drugs that improve LDL-C. Positive...


Jun 09, 2016, 13:03 ET Decision Resources Group Analysts Highlight Key Trends Stemming from ASCO's 2016 Annual Meeting

Analysts from Decision Resources Groups' Oncology team share their insights and analysis on the key trends that were presented at the American...


Jun 07, 2016, 12:00 ET Decision Resources Group Study Finds Forty Three Percent of U.S. Physicians Struggle to Keep Up With Changing Healthcare System

 Decision Resources Group finds that U.S. physicians are struggling to keep up with a fast-changing healthcare system. New goals reflect the...


Jun 01, 2016, 10:08 ET The Newly Launched IL-17 Inhibitor Cosentyx is Gradually Gaining Momentum in the EU5, While Established Subcutaneous TNF-Alpha Inhibitors Humira and Enbrel Continue to Dominate Biologics Patient Share in Psoriasis

 Decision Resources Group finds that in the EU5, while surveyed dermatologists prefer subcutaneous TNF-alpha inhibitors AbbVie's Humira and...


May 24, 2016, 10:00 ET Decision Resources Group Cited in ACO Performance Benchmarking Study

Decision Resources Group (DRG) today announced that data from its market-leading database, Organized Customer Group Navigator (OCGN), was cited in...


Apr 19, 2016, 09:00 ET Decision Resources Group Launches Real World Evidence With Coverage of 90% of U.S. Healthcare System

BURLINGTON, Mass., April 19, 2016 /PRNewswire/ -- Decision Resources Group (DRG) today announced that it has launched a Real World Evidence...


Apr 13, 2016, 09:12 ET Decision Resources Group Appoints Jonathan Sandler as Chief Executive Officer

 Decision Resources Group (DRG), a subsidiary of India-based Piramal Enterprises Limited (Piramal), today announced that its Board of Directors...


Mar 14, 2016, 09:45 ET Decision Resources Group Expands Product Sales in Latin America through Strategic Alliance with Close-Up International

 Decision Resources Group (DRG) today announced that it has formed a strategic alliance with Close-Up International (CUI), a global leader in...


Feb 29, 2016, 14:30 ET Decision Resources Group Expands into Healthcare Payer Market

 Decision Resources Group (DRG) today announced that it has acquired Adaptive Software (Adaptive), developers of market-leading pharmacy...


Jan 06, 2016, 08:30 ET Decision Resources Group Unifies Portfolio Under DRG Brand

 Decision Resources Group (DRG) announced that it has unified its portfolio of best-in-class companies under one brand. "The healthcare...


Dec 28, 2015, 08:30 ET Several Therapies to Launch for Hemophilia A, Hemophilia B and Hemophilia with Inhibitors in the U.S. and E.U. through 2025

 Decision Resources Group forecasts that several therapies will launch for hemophilia A, hemophilia B and hemophilia with inhibitors in the...


Dec 28, 2015, 08:30 ET Several Therapies to Launch for Hemophilia A, Hemophilia B and Hemophilia with Inhibitors in the U.S. and E.U. through 2025

 Decision Resources Group forecasts that several therapies will launch for hemophilia A, hemophilia B and hemophilia with inhibitors in the...


Dec 22, 2015, 08:30 ET The Rising Prevalence of Diabetes and its Confounding Complications

 Decision Resources Group finds that the prevalent type 2 diabetes (T2D) population in the G7 (United States, France, Germany, Italy, Spain,...


Dec 22, 2015, 08:30 ET The Rising Prevalence of Diabetes and its Confounding Complications

 Decision Resources Group finds that the prevalent type 2 diabetes (T2D) population in the G7 (United States, France, Germany, Italy, Spain,...


Dec 21, 2015, 08:30 ET Novel Agents Are Set To Reverse The Decline In The Osteoporosis Market

 Decision Resources Group finds that, according to the Osteoporosis Pharmacor report, published December 2015, the osteoporosis market is...


Dec 21, 2015, 08:30 ET Novel Agents Are Set To Reverse The Decline In The Osteoporosis Market

 Decision Resources Group finds that, according to the Osteoporosis Pharmacor report, published December 2015, the osteoporosis market is...


Dec 18, 2015, 08:30 ET The Launches of Novel Routine Prophylactic Agents with Improved Administration Convenience Will Reshape the Hereditary Angioedema Market

 Decision Resources Group finds that the anticipated approvals of several prophylactic agents, including BioCryst's avoralstat and BCX-7353,...


Dec 18, 2015, 08:30 ET The Launches of Novel Routine Prophylactic Agents with Improved Administration Convenience Will Reshape the Hereditary Angioedema Market

 Decision Resources Group finds that the anticipated approvals of several prophylactic agents, including BioCryst's avoralstat and BCX-7353,...


Dec 17, 2015, 08:30 ET The Global Structural Heart Closure Device Market will Experience Strong Growth Through 2024, Driven Primarily by the Uptake of Endocardial LAA Closure for Stroke Prevention in Atrial Fibrillation Patients

 Decision Resources Group finds that the global structural heart closure device market will grow robustly over the next ten years, driven...


Dec 17, 2015, 08:30 ET The Global Structural Heart Closure Device Market will Experience Strong Growth Through 2024, Driven Primarily by the Uptake of Endocardial LAA Closure for Stroke Prevention in Atrial Fibrillation Patients

 Decision Resources Group finds that the global structural heart closure device market will grow robustly over the next ten years, driven...


Dec 16, 2015, 10:00 ET PCSK9 Inhibitors Set to Achieve Blockbuster Status Despite Constraints on Use

 Decision Resources Group finds that the recently launched proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor class will be a key...